Mangilipally, S., Lingala, D., Dusa, J., S, A. T., Bogi, N., Aeluka, R., & D, P. (2026). Regulatory Pathways for Generic Antiviral Drugs: ANDA Requirements in the USA Compared With BRICS. International Journal of Life Science and Pharma Research, 16(3), 64–75. https://doi.org/10.22376/ijlpr.v16i3.2059